What shapes an injection decision
A licence search answers a licence question
Washington's official search shows clinician and pharmacy licence records, as of the September 30, 2026 state check. The state says an empty record of discipline does not guarantee skill or recommend someone. A
Discipline means state action against a licence. Match the name, kind of licence and whether it is active. For the proposed drug, look for the drug's records.
Talk through the injection plan
A law and a board note do different jobs
Telehealth means care given from a distance. Washington's Uniform Telehealth Act is a law that requires the same level of care remotely as for the same visit in person. This law was checked on September 30, 2026. B
Washington's semaglutide ingredient statement explains how the Pharmacy Commission applies drug law; the statement itself is not a new law. C
The Pharmacy Commission also sent pharmacies a written reminder, called a bulletin, in July 2026. It rejects ingredients marked 'not for human consumption' or 'research use only' for medicines made to order for patients. Those words mean the ingredient is labelled for study, not for use in people. The reminder was still current at the September 30, 2026 check. D
The bulletin explains existing drug rules; it is not a new law. D
Ask, 'Where does this claim come from?' Then ask whether the document is a law, advice or a proposed change. A proposed change means someone is asking for a new rule. Ask whether it has become a rule yet.
What shapes an injection decision
A product code cannot prove approval
FDA means the Food and Drug Administration. Its National Drug Code Directory is a list of identifying numbers for drug products. A product being on that list does not mean the FDA approved it. This was checked on September 26, 2026. E
If an offer points to a code as proof, ask for the product's approval record instead.
Talk through the injection plan
A report is a clue, not proof of cause
The FDA says a report cannot prove that a medicine caused the problem or show how often that problem happens. F
In a warning letter, the FDA puts its concerns to a company as they stood when the letter was sent. It is not a final finding. Later contact between the FDA and the company may change where the matter stands. G
Ask whether the concern is still open and whether there is a later reply or closing letter. The old letter alone cannot tell you whether the concern was fixed.
Look for the date. Ask what the record can tell you about the product or care you are considering.
Take the exact product name and the claim you want checked into your next conversation.